T-Mobile US Inc. buy BiotechBee
Summary
This prediction ended on 05.05.23 with a price of €127.92. With a performance of -8.76%, the BUY prediction by BiotechBee finished with a loss. BiotechBee has 70% into this predictionT-Mobile US (Symbol: TMUS) is a leading American telecommunications company providing wireless voice, messaging, and data services to millions of customers across the United States. Known for its innovative and customer-centric approach, TMUS operates under the flagship brand T-Mobile and also includes other prominent subsidiaries like Metro by T-Mobile, offering a diversified range of mobile services and solutions. As the third-largest wireless carrier in the US, T-Mobile US has consistently spearheaded the industry's evolution with its rapid expansion of 5G networks, competitive pricing strategies, and unique promotional offers, catering to both individual and business clients. With a strong financial performance and a commitment to excellent customer service, T-Mobile US plays a significant role in shaping the future of wireless communications in the country.
Performance without dividends (%)
| Name | 1w | 1m | 1y | 3y |
|---|---|---|---|---|
| T-Mobile US Inc. | 10.761% | 10.761% | -27.063% | 35.230% |
| iShares Core DAX® | 0,46 % | -2,00 % | 9,98 % | 58,55 % |
| iShares Nasdaq 100 | -1,79 % | -5,74 % | -0,78 % | 80,51 % |
| iShares Nikkei 225® | 5,12 % | 9,09 % | 28,82 % | 62,78 % |
| iShares S&P 500 | -1,76 % | -3,67 % | -0,54 % | 54,39 % |
According to BiotechBee what are the pros and cons of T-Mobile US Inc. for the foreseeable future?
Pros
Cons
Comments by BiotechBee for this prediction
In the thread T-Mobile Us Inc. diskutieren